The Lynx Group

John A. Thompson, MD


Authored Items

Immunotherapy Takes Center Stage in NCCN Advanced Melanoma Guideline

May 2016, Vol. 5, No. 4 - National Comprehensive Cancer Network

The revised guideline (Version 2.2016) for the management of advanced melanoma, released by the National Comprehensive Cancer Network (NCCN), shows increasing appreciation for the use of immune checkpoint inhibitors and targeted agents, as more data establish these drug classes as having superior efficacy to traditional chemotherapy. “We’ve seen the approval [ Read More ]

Sign me up!